Catalog No.
FHF86312
Species reactivity
Human
Host species
Mouse
Isotype
IgG1, kappa
Clonality
Monoclonal
Conjugation
PE
Applications
FCM
Target
IL-5R subunit alpha, IL-5 receptor subunit alpha, IL5RA, IL-5RA, IL-5R-alpha, Interleukin-5 receptor subunit alpha, CDw125, CD125, IL5R
Concentration
0.5 mg/ml
Endotoxin level
Please contact with the lab for this information.
Accession
Q01344
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300.
Stability and Storage
Store at 4°C for 12 months. Protect from light. Do not freeze.
Clone ID
SAA0047
Note
For research use only.
Novel technique for the direct flow cytofluorometric analysis of human basophils in unseparated blood and bone marrow, and the characterization of phenotype and peroxidase of human basophils., PMID:10082306
Kinetic interaction analysis of human interleukin 5 receptor alpha mutants reveals a unique binding topology and charge distribution for cytokine recognition., PMID:14662768
Immunohistochemical analysis of an ectopic endometriosis in the uterine round ligament., PMID:16961927
Structure-based rationale for interleukin 5 receptor antagonism., PMID:18473871
Establishment of humanized anti-interleukin-5 receptor alpha chain monoclonal antibodies having a potent neutralizing activity., PMID:19478395
Antigen profiles for the quantitative assessment of eosinophils in mouse tissues by flow cytometry., PMID:21565196
Flow cytometry analysis of leukocytes in induced sputum from asthmatic patients., PMID:22204819
Regulatory T-cell responses in chronic hepatitis B patients treated with nucleos(t)ide analogs compared with healthy subjects and untreated infected individuals., PMID:22626879
Disentangling the effects of tocilizumab on neutrophil survival and function., PMID:26721805
A Simple, Rapid, and Highly Sensitive Electrochemical DNA Sensor for the Detection of α- and β-Thalassemia in China., PMID:27228385
The role of interleukin 5 in asthma., PMID:27450970
Efficacy and Safety of Benralizumab, a Monoclonal Antibody against IL-5Rα, in Uncontrolled Eosinophilic Asthma., PMID:27119985
B-cells with a FasL expressing regulatory phenotype are induced following successful anti-tuberculosis treatment., PMID:28250925
Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma., PMID:28530840
FACS isolation of live mouse eosinophils at high purity via a protocol that does not target Siglec F., PMID:29253503
Benralizumab for the treatment of asthma., PMID:29517082
Reslizumab Compared with Benralizumab in Patients with Eosinophilic Asthma: A Systematic Literature Review and Network Meta-Analysis., PMID:30217529
Benralizumab for PDGFRA-Negative Hypereosinophilic Syndrome., PMID:30943337
Longitudinal trends of serum IgE and IL5RA expression throughout childhood are associated with asthma but not with persistent wheeze., PMID:31012487
A case of severe eosinophilic asthma and refractory rheumatoid arthritis well controlled by combination of IL-5Rα antibody and TNFα inhibitor., PMID:31027977
Targeting IL-5 in COPD., PMID:31190789
Eosinophils Affect Antibody Isotype Switching and May Partially Contribute to Early Vaccine-Induced Immunity against Coxiella burnetii., PMID:31427447
Eosinophils, the IL-5/IL-5Rα axis, and the biologic effects of benralizumab in severe asthma., PMID:31734469
IL-5Rα marks nasal polyp IgG4- and IgE-expressing cells in aspirin-exacerbated respiratory disease., PMID:32199912
Efficacy of Benralizumab and Clinical Course of IgG4 in Eosinophilic Granulomatosis With Polyangiitis., PMID:33030432
Unsustained Response to Benralizumab in Eosinophilic Asthma After 3 Years of Therapy With Mepolizumab., PMID:33136004
Genomic and phenotypic characterization of Investigator Global Assessment (IGA) scale-based endotypes in atopic dermatitis., PMID:33421484
Engineering of Humanized Antibodies Against Human Interleukin 5 Receptor Alpha Subunit That Cause Potent Antibody-Dependent Cell-Mediated Cytotoxicity., PMID:33488590
Molecular mechanism of asthma and its novel molecular target therapeutic agent., PMID:33549541
The efficacy of off-label IL-5-modulating treatment in rare eosinophil-mediated diseases., PMID:33779559
Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease., PMID:34144111
Are serum immunoglobulin concentrations a predictive biomarker of response to anti-IL5/IL5Rα therapies?, PMID:34983012
Optimized flow cytometry protocol for dihydrorhodamine 123-based detection of reactive oxygen species in leukocyte subpopulations in whole blood., PMID:35760097
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis., PMID:38393328
Flow cytometric immunophenotypic differentiation patterns of bone marrow eosinophilopoiesis., PMID:38666394
Effect of benralizumab on inflammation in skin after intradermal allergen challenge in patients with moderate-to-severe atopic dermatitis., PMID:39234416
Revolutionizing acute myeloid leukemia treatment: a systematic review of immune-based therapies., PMID:39864030
Remarkable increase in Interleukin-5 receptor expression beyond tissue eosinophils in inflammatory bowel disease., PMID:40475764
For research use only. Not for human or drug use.
